Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Our AI scores Anteris Technologies Global Corp. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Anteris Technologies Global Corp. is a small-cap company with a market capitalization of $555M. It ranks number 10 by market capitalization among the 26 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.
For AVR, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 15.0%, measured on 214 forecast dates between 2025-05-16 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 32.0%, measured on 257 forecast dates between 2025-05-16 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, AVR included.
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
| Metric | AVR | Rank |
|---|---|---|
| Market Cap | $555M | 10/26 |
| P/B Ratio | 2.21x | 11/20 |
| EPS | $-2.27 | – |
| Book Value/Share | $2.58 | – |
| Revenue/Share | $0.02 | – |
| FCF/Share | $-0.91 | – |
| Metric | AVR | Rank |
|---|---|---|
| ROIC | -41.8% | 15/21 |
| Operating Margin | -6077.5% | 19/20 |
| EBT Margin | -5859.0% | 19/20 |
| Tax Rate | -0.5% | – |
| Metric | AVR | Rank |
|---|---|---|
| Current Ratio | 14.20x | 2/24 |
| Quick Ratio | 14.20x | 1/21 |
| D/E Ratio | 0.08x | 22/23 |
| Financial Leverage | 1.08x | 22/23 |
| Interest Coverage | -298.1x | 17/20 |
| Working Capital | $242M | 8/24 |
| Metric | AVR | Rank |
|---|---|---|
| Operating Cash Flow | -$86M | 24/24 |
| Free Cash Flow | -$88M | 15/15 |
| Capital Spending | -$2M | 7/15 |
| FCF/Sales | -5046.3% | 15/15 |
| CapEx/Sales | 111.8% | 1/15 |
| Metric | AVR | Rank |
|---|---|---|
| Asset Turnover | 0.01x | 17/17 |
| Receivables Turnover | 3.2x | 15/16 |
| Inventory Turnover | 70.1x | 1/21 |
| Fixed Assets Turnover | 0.3x | 17/18 |
| Days Sales Outstanding | 114 days | 2/16 |
| Days Inventory | 5 days | 21/21 |
| Payables Period | 3318 days | 2/18 |
| Cash Conversion Cycle | -3198 days | 13/14 |
| Metric | AVR | Rank |
|---|---|---|
| Total Revenue | $2M | 16/18 |
| Operating Income | -$106M | 23/24 |
| R&D Expense | $77M | 7/21 |
| SG&A Expense | $31M | 15/21 |
| Cost of Goods Sold | $560K | 20/21 |
| Metric | AVR | Rank |
|---|---|---|
| Shares Outstanding | 97M | – |
| Total Current Assets | $261M | 95.9% of assets |
| Cash & Short-term Investments | $250M | 92.0% of assets |
| Accounts Receivable | $550K | 0.2% of assets |
| Inventory | $10K | 0.0% of assets |
| Total Liabilities | $21M | 7.7% of assets |
| Short-term Debt | $13M | 4.9% of assets |
Companies classified under the same SEC industry code as Anteris Technologies Global Corp. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 26 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| AVR Anteris Technologies Global Corp. | $555M | |
| ISRG Intuitive Surgical Inc | $156.96B | |
| STE Steris Plc | $24.60B | |
| ZBH Zimmer Biomet Holdings, Inc. | $20.38B | |
| SNN Smith & Nephew Plc | $13.67B | |
| ALGN Align Technology Inc | $11.79B | |
| MSA Msa Safety Inc | $6.56B | |
| ESTA Establishment Labs Holdings Inc. | $1.92B | |
| ENOV Enovis Corp | $1.57B | |
| CDRE Cadre Holdings, Inc. | $1.40B | |
| SMTI Sanara Medtech Inc. | $290M | |
| INGN Inogen Inc | $160M | |
| LAKE Lakeland Industries Inc | $89M | |
| NTRB Nutriband Inc. | $68M | |
| APT Alpha Pro Tech Ltd | $56M | |
| COCH Envoy Medical, Inc. | $55M | |
| MYO Myomo, Inc. | $48M | |
| MLSS Milestone Scientific Inc. | $27M | |
| LFWD Lifeward Ltd. | $16M | |
| CUPR Cuprina Holdings (Cayman) Ltd | $12M | |
| UEEC United Health Products, Inc. | $10M | |
| RGNT Regentis Biomaterials Ltd. | $8M | |
| CLGN Collplant Biotechnologies Ltd | $7M | |
| BBLG Bone Biologics Corp | $1M | |
| FEED Envue Medical, Inc. | $240K | |
| RBOT Vicarious Surgical Inc. | $10K |
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Detailed price information for Anteris Technologies Global Corp (AVR-Q) from The Globe and Mail including charting and trades.
So thank you all for joining. I'm very excited to welcome Wayne Paterson, CEO of Anteris. There is a disclaimer on the Morgan Stanley website that I encourage people to look at. Anteris, for those who ...
Our AI scores Anteris Technologies Global Corp. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
For AVR, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 15.0%, measured on 214 forecast dates between 2025-05-16 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 32.0%, measured on 257 forecast dates between 2025-05-16 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Anteris Technologies Global Corp. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
26 issuers in our coverage, AVR included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Smith & Nephew Plc (SNN), Align Technology Inc (ALGN), Msa Safety Inc (MSA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.
